An Australian-first trial using medicinal cannabis to treat returned servicemen and women suffering from post-traumatic stress disorder (PTSD) has been launched today that targets defence personnel who have not had a response to conventional treatments.
Researchers are seeking 300 people to take part in the national trial, which has attracted attention from the veteran community
The Australian Defence Force reports about 8.3 per cent of its members have experienced PTSD in the past 12 months
The ADF says the rate among males is almost double the general community
The investigation, coordinated by Cannabis Access Clinics, will run over the next 12 months.
Lead researcher Dr Sharron Davis said traditional treatments did not really work for PTSD.
“It can present itself in lots of different ways, so it’s very difficult to find a treatment that is going to treat all of the symptoms of PTSD,” Dr Davis said.
Researchers are seeking 300 people to take part in the national trial, which has already attracted attention from the veteran community.
“We have to be able to show the Therapeutic Goods Administration that these people have tried everything conventional medicine has to offer,” Dr Davis said.
The study will see individuals prescribed a baseline dose of the oil that uses the non-psychoactive part of medicinal cannabis, referred to as CBD.
Read full article>> https://www.abc.net.au/news/2019-06-12/medicinal-cannabis-treatment-trial-for-veterans-with-ptsd/11200136
Using a Telehealth model, our 15 minute screening appointments provide a quick and convenient way to assess the suitability of a patient’s condition for treatment prior to discussing options with their own doctor.